Thomas Talbot
-
December 5, 2017
Vanderbilt receives national designation for excellence in infection prevention
Vanderbilt University Medical Center (VUMC) is the first health system in the nation to receive the Association for Professionals in Infection Control and Epidemiology (APIC) Program of Distinction designation, an acknowledgement of excellence for infection prevention and control programs that meet stringent standards established by the association. -
October 19, 2017
Room-cleaning robots use UV radiation to zap microorganisms
Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center (VUMC) patients from health care-associated infections. -
October 20, 2015
A bundle, a dashboard and lasting pneumonia reduction
A “bundle” of electronically implemented care guidelines reduced intensive care unit patient complications related to mechanical ventilation. -
October 7, 2014
Ebola not likely, but VUMC is prepared
Armed with a validated and orchestrated plan, Vanderbilt University Medical Center is prepared to safely and effectively treat patients with the bloodborne disease Ebola, should the need arise. -
September 24, 2014
Alexander’s visit highlights efforts to confront Ebola
Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee. -
October 10, 2013
Talbot lands epidemiology award
Thomas Talbot, M.D., MPH, associate professor of Medicine and Chief Hospital Epidemiologist at Vanderbilt University Medical Center, received the 2013 Investigator Award from the Society for Healthcare Epidemiology of America (SHEA) at the organization’s Annual Scientific Meeting last week in San Francisco. -
April 4, 2013
Vanderbilt researchers work to balance flu vaccine debate
Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot's effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.